These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11721634)

  • 41. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
    Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
    Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteomics in thyroid tumor research.
    Krause K; Jessnitzer B; Fuhrer D
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2717-24. PubMed ID: 19470617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic Analysis of Stage-II Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues.
    Abdullah Al-Dhabi N; Srigopalram S; Ilavenil S; Kim YO; Agastian P; Baaru R; Balamurugan K; Choi KC; Valan Arasu M
    Biomed Res Int; 2016; 2016():3071013. PubMed ID: 27110560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry.
    Calderón-González KG; Valero Rustarazo ML; Labra-Barrios ML; Bazán-Méndez CI; Tavera-Tapia A; Herrera-Aguirre ME; Sánchez del Pino MM; Gallegos-Pérez JL; González-Márquez H; Hernández-Hernández JM; León-Ávila G; Rodríguez-Cuevas S; Guisa-Hohenstein F; Luna-Arias JP
    J Proteomics; 2015 Jun; 124():50-78. PubMed ID: 25918110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of laser capture microdissected cells by 2-dimensional gel electrophoresis.
    Zhang D; Koay ES
    Methods Mol Biol; 2008; 428():77-91. PubMed ID: 18287769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative proteome analysis of human lung squamous carcinoma using two different methods: two-dimensional gel electrophoresis and iTRAQ analysis.
    Zeng GQ; Zhang PF; Li C; Peng F; Li MY; Xu Y; Yu FL; Chen MJ; Yi H; Li GQ; Chen ZC; Xiao ZQ
    Technol Cancer Res Treat; 2012 Aug; 11(4):395-408. PubMed ID: 22417063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer proteomics: from biomarker discovery to signal pathway profiling.
    Bichsel VE; Liotta LA; Petricoin EF
    Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomics in gastrointestinal cancer.
    Ebert MP; Yu J; Lordick F; Röcken C
    Ann Oncol; 2006 Sep; 17 Suppl 10():x253-8. PubMed ID: 17018734
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach.
    Rosty C; Goggins M
    Methods Mol Med; 2005; 103():189-97. PubMed ID: 15542907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
    Le Naour F; Misek DE; Krause MC; Deneux L; Giordano TJ; Scholl S; Hanash SM
    Clin Cancer Res; 2001 Nov; 7(11):3328-35. PubMed ID: 11705844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human.
    Deng SS; Xing TY; Zhou HY; Xiong RH; Lu YG; Wen B; Liu SQ; Yang HJ
    Genomics Proteomics Bioinformatics; 2006 Aug; 4(3):165-72. PubMed ID: 17127214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic profiling of cancer biomarkers.
    Shau H; Chandler GS; Whitelegge JP; Gornbein JA; Faull KF; Chang HR
    Brief Funct Genomic Proteomic; 2003 Jul; 2(2):147-58. PubMed ID: 15239937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.
    Wu C; Luo Z; Chen X; Wu C; Yao D; Zhao P; Liu L; Shi B; Zhu L
    Oncol Rep; 2009 Jun; 21(6):1429-37. PubMed ID: 19424620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
    Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.
    Kulkarni YM; Suarez V; Klinke DJ
    BMC Cancer; 2010 Jun; 10():291. PubMed ID: 20550684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.